Huuskonen Jarkko, Vishnu Meeta, Pullinger Clive R, Fielding Phoebe E, Fielding Christopher J
Cardiovascular Research Institute, San Francisco, California 94143-0130, USA.
Biochemistry. 2004 Feb 17;43(6):1626-32. doi: 10.1021/bi0301643.
Transcriptional regulation of the ATP-binding cassette transporter (ABCA1) gene is complex. It involves multiple transcription start sites and the binding of several different transcription factors to the ABCA1 promoter region. Cholesterol- and oxysterol-mediated up-regulation of ABCA1 transcription includes the binding of the liver X receptor and retinoid X receptor (LXR/RXR) heterodimer to the DR-4 element of the ABCA1 promoter. In this study we show that another nuclear hormone receptor, thyroid hormone receptor (TR), can suppress ABCA1 transcription. Electrophoretic mobility shift assays using both purified proteins and isolated nuclear extracts from primary human fibroblasts and 293T cells demonstrate that the TR/RXR heterodimer is able to bind to the DR-4 element of the ABCA1 promoter. This binding is also demonstrated in vivo by chromatin immunoprecipitation studies. Luciferase assays from 293T cells transfected with TRbeta or LXRalpha expression plasmids show that TR, together with its ligand T3, suppresses ABCA1 transcriptional activity, even in the presence of LXR-activating oxysterols. Finally, competition between TR/RXR and LXR/RXR heterodimers to suppress or activate ABCA1 transcription is shown to be dynamic and dependent on the amount of nuclear receptor present in the cells. These data identify a novel regulatory mechanism for ABCA1 and suggest new strategies to modify its expression.
ATP结合盒转运蛋白(ABCA1)基因的转录调控十分复杂。它涉及多个转录起始位点以及几种不同转录因子与ABCA1启动子区域的结合。胆固醇和氧化甾醇介导的ABCA1转录上调包括肝X受体和视黄酸X受体(LXR/RXR)异二聚体与ABCA1启动子的DR-4元件结合。在本研究中,我们发现另一种核激素受体,即甲状腺激素受体(TR),能够抑制ABCA1转录。使用纯化蛋白以及从原代人成纤维细胞和293T细胞中分离的核提取物进行的电泳迁移率变动分析表明,TR/RXR异二聚体能够与ABCA1启动子的DR-4元件结合。染色质免疫沉淀研究在体内也证实了这种结合。用TRβ或LXRα表达质粒转染的293T细胞进行的荧光素酶分析表明,即使在存在激活LXR的氧化甾醇的情况下,TR与其配体T3一起也会抑制ABCA1的转录活性。最后,TR/RXR和LXR/RXR异二聚体之间抑制或激活ABCA1转录的竞争被证明是动态的,并且取决于细胞中存在的核受体数量。这些数据确定了ABCA1的一种新调控机制,并提出了改变其表达的新策略。